333D Limited (T3D) AI Stock Analysis

• Market Cap: AU$5.84M
• Dividend Yield: N/A
• Average Volume (3M): 1.82M
• Price to Earnings (P/E): 145.0
• Beta (1Y): -0.11
• Revenue Growth: 426.44%
• EPS Growth: N/A
• Country: AU
• Employees: N/A
• Sector: Technology
• Sector Strength: 88
• Industry: Computer Hardware
• EPS (TTM): >-0.01
• Shares Outstanding: 201,520,480
• 10 Day Avg. Volume: 946,403
• 30 Day Avg. Volume: 1,817,650
• PEG Ratio: -0.06
• Price to Book (P/B): -21.32
• Price to Sales (P/S): 0.95
• P/FCF Ratio: 13.56
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0
• EPS Forecast (FY): N/A
• Revenue Forecast (FY): N/A

• Rating: 42 Neutral
• Price Target: AU$0.03 ▼(-6.67% Downside)
• Action: Reiterated Date: 02/10/26
• Date: Action: Reiterated 02/10/26

The score is held down primarily by balance-sheet fragility (negative equity) and a history of volatile earnings/cash flow despite a strong FY2025 rebound. Technicals add further pressure with a weak trend and bearish momentum. Valuation is also demanding (high P/E), limiting upside unless the turnaround proves durable.

Positive Factors

Revenue and Profit Rebound

FY2025's ~60% revenue rebound and return to ~14% net margin indicate improved unit economics and operational leverage. Sustained top-line growth with higher margins can generate internal funding for reinvestment, cover fixed costs more easily, and form the basis for a durable recovery over the medium term.

Positive Cash Generation

Positive operating and free cash flow in FY2025 marks a material improvement versus prior cash burn years. Reliable cash conversion reduces dependence on external financing, supports working capital and modest capex, and provides a foundation for stabilizing operations if the company can maintain consistent cash generation.

Low Financial Leverage

Reported zero total debt through FY2025 keeps fixed financial obligations low and reduces default risk. A low-leverage profile provides strategic flexibility to allocate cash toward operations or investment and improves resilience during a multi-year turnaround, assuming liquidity and equity issues are managed.

Negative Factors

Negative Shareholders' Equity

Negative shareholders' equity reflects accumulated losses and capital erosion, weakening solvency buffers. This condition constrains access to traditional financing, increases counterparty and investor caution, and structurally raises the likelihood of future equity injections or dilutive recapitalizations to restore balance-sheet health.

Earnings and Cash-flow Volatility

Persistent losses across FY2020–FY2024 and inconsistent cash flows undermine predictability and planning. Such volatility elevates the company's cost of capital, complicates supplier and customer relationships, and makes it harder to demonstrate a sustainable earnings trajectory necessary for durable operational improvements.

Thin Capital Base and Refinancing Risk

A thin capital base and negative equity materially limit financial flexibility, increasing the risk that setbacks force dilutive equity raises or expensive financing. This structural constraint can hamper long-term investments, strategic initiatives, and the company's ability to withstand industry headwinds without external support.

333D Limited Business Overview & Revenue Model

Company Description

333D Limited, together with its subsidiaries, provides 3D printing services in Australia. The company offers 3D printing equipment and consumables; and sells 3D prints. 333D Limited was incorporated in 2006 and is based in Laverton North, Australia.

How the Company Makes Money

333D Limited generates revenue primarily through the sale of 3D printed products and services. The company offers customized 3D printing solutions to various sectors, enabling clients to create prototypes, models, and finished goods. Additionally, 333D Limited may engage in partnerships with other businesses to expand its market reach and enhance its product offerings. The company could also explore opportunities in licensing its technology or collaborating on research and development initiatives to further drive its revenue streams. However, specific details about significant partnerships or additional revenue factors are currently unavailable.

333D Limited Financial Statement Overview

Summary

FY2025 shows a strong rebound (revenue up ~60%, return to positive net profit with ~14% margin, and positive operating/free cash flow). However, multi-year profitability and cash-flow volatility plus negative shareholders’ equity in FY2025 materially elevate risk and reduce confidence in durability.

Income Statement

The latest annual period (FY2025) shows a sharp rebound with revenue up ~60% and a return to positive net profit (~14% margin), supported by a healthier gross margin (~40%). However, profitability has been highly volatile: FY2020–FY2024 featured persistent losses and, in several years, deeply negative margins, which raises questions around earnings durability and the consistency of the underlying business model.

Balance Sheet

Leverage is currently low (total debt reported at zero in FY2022–FY2025), which reduces financial risk. The key weakness is solvency: shareholders’ equity is negative in FY2025 (and was materially negative across several prior years), implying accumulated losses and a thin capital base. Total assets increased in FY2025, but negative equity limits balance-sheet flexibility and can increase refinancing/raising-capital risk if performance weakens.

Cash Flow

Cash generation improved in FY2025 with positive operating and free cash flow (~$70.7k), a meaningful step up from cash burn in FY2022–FY2024. That said, cash flow has been inconsistent year-to-year (including sizable outflows in FY2023 and FY2022), and FY2025 free cash flow declined versus the prior period on the provided growth metric. Overall, cash flow is improving but not yet stable enough to be viewed as structurally strong.

Breakdown	TTM	Jun 2025	Jun 2024	Jun 2023	Jun 2022	Jun 2021
Income Statement
Total Revenue	1.11M	1.01M	190.31K	23.95K	63.68K	114.97K
Gross Profit	540.53K	403.08K	181.29K	-146.37K	-209.88K	-24.78K
EBITDA	-182.13K	144.81K	-600.60K	-836.10K	-1.22M	-488.88K
Net Income	8.97K	143.78K	-506.61K	-724.97K	-1.24M	-338.79K
Balance Sheet
Total Assets	1.12M	641.11K	24.68K	89.29K	441.52K	132.40K
Cash, Cash Equivalents and Short-Term Investments	736.33K	75.27K	4.58K	65.05K	415.73K	99.21K
Total Debt	0.00	0.00	0.00	0.00	0.00	300.00K
Total Liabilities	385.73K	686.08K	553.85K	505.88K	365.68K	678.88K
Stockholders Equity	735.03K	-44.96K	-529.17K	-416.60K	75.84K	-546.47K
Cash Flow
Free Cash Flow	424.93K	70.68K	-60.46K	-350.69K	-195.78K	90.04K
Operating Cash Flow	424.93K	70.68K	-60.46K	-350.69K	-195.78K	90.04K
Investing Cash Flow	-370.50K	0.00	0.00	0.00	0.00	0.00
Financing Cash Flow	629.57K	0.00	0.00	0.00	512.30K	0.00

333D Limited Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
Sector *	61 Neutral	$37.18B	12.37	-10.20%	1.83%	8.50%	-7.62%
CT1	61 Neutral	AU$2.95M	―	1.10%	―	34.27%	―
T3D	42 Neutral	AU$5.84M	145.00	―	―	426.44%	―
1TT	37 Underperform	AU$1.43M	-0.17	―	―	―	―

333D Limited Corporate Events

333D Lifts Revenue and NTA but Posts Wider Annual Loss

333D Limited reported revenue from ordinary activities of $588,678 for the year ended 31 December 2025, a 23% increase on the prior year, indicating improving top-line performance in its operations. However, the company recorded a net loss attributable to members of $282,030, down 92% compared with the previous year’s result, and the directors again decided not to declare a dividend for the period.

Despite the loss, 333D’s net tangible assets per share improved materially to 0.365 cents from a negative 0.029 cents a year earlier, signalling a stronger balance sheet position for shareholders. The interim financial report for the half-year ended 31 December 2025 was reviewed without any material uncertainty regarding going concern, providing some reassurance to investors about the company’s financial stability and ongoing operations.

The most recent analyst rating on (AU:T3D) stock is a Sell with a A$0.03 price target. To see the full list of analyst forecasts on 333D Limited stock, see the AU:T3D Stock Forecast page.

333D Flags Material Impairment in Bitcoin Treasury Holdings

333D Limited has reported that the market value of its Bitcoin treasury holdings stood at $228,838 as at 1 February 2026, representing an impairment of $141,661, or 13.6% of the consolidated group’s total assets, thereby triggering its continuous disclosure obligations under ASX Listing Rule 3.1. The company attributed the decline in the Australian dollar value of its Bitcoin position to a combination of cryptocurrency price volatility and a strengthening Australian dollar against the US dollar, and noted that it does not currently hedge its cryptocurrency or foreign exchange exposures, meaning investors should expect ongoing variability in reported valuations as part of its broader digital asset treasury strategy.

The most recent analyst rating on (AU:T3D) stock is a Hold with a A$0.04 price target. To see the full list of analyst forecasts on 333D Limited stock, see the AU:T3D Stock Forecast page.

333D posts sixth straight quarter of revenue growth and advances blockchain healthcare push

333D Limited reported its sixth consecutive quarter of growth in cash receipts, generating $330,917 from digital asset management contracts in the December quarter, reflecting a 3.92% increase and underscoring the success of its strategic pivot into healthcare-focused digital asset management. The company recorded net operating cash outflows of $99,180 on quarterly expenditure of about $430,097, ended the period with combined cash and Bitcoin holdings of $993,691, and highlighted progress in its BioScan 360 collaboration, having successfully stored full body MRI scan data on the blockchain with plans to scale this decentralised, patient-controlled data solution across the preventative healthcare market.

The most recent analyst rating on (AU:T3D) stock is a Hold with a A$0.05 price target. To see the full list of analyst forecasts on 333D Limited stock, see the AU:T3D Stock Forecast page.

333D Limited Announces Director’s Acquisition of Performance Rights

333D Limited has announced a change in the director’s interest, specifically involving Dr. Richard Petty, who has acquired 1,000,000 performance rights as part of the company’s Long Term Incentive Plan. This acquisition was made without cash consideration, indicating a strategic move to align the director’s interests with the company’s long-term goals, potentially impacting the company’s governance and stakeholder confidence.

333D Limited Updates Director’s Interest with New Incentives

333D Limited has announced a change in the director’s interest, specifically involving Dr. Nigel Finch. The change involves the acquisition of 750,000 performance rights by Saki Partners (Services) Pty Ltd, a company controlled by Dr. Finch, as part of the company’s Long Term Incentive Plan. This move increases the total performance rights held by Saki Partners to 2,250,000, reflecting the company’s strategy to incentivize its leadership.